Loading Bonafide Research

Global Computed Tomography (Ct) Market Outlook, 2030

The Global Computed Tomography (CT) sector is forecast to grow at more than 6.49% CAGR from 2024 to 2029, driven by the increasing need for detailed imaging.

The global Computed Tomography (CT) market plays a crucial role in advanced medical imaging, providing high-resolution, cross-sectional scans of the human body for accurate diagnosis and treatment planning. CT scans use X-ray beams and computer-processed algorithms to create detailed images of internal organs, bones, blood vessels, and soft tissues, making them essential in neurology, oncology, cardiology, trauma care, and interventional procedures. Hospitals, diagnostic imaging centers, and specialized clinics rely on multi-slice CT scanners, cone-beam CT (CBCT), and high-speed dual-energy CT systems for precise medical evaluations. Emergency departments use CT scans for rapid assessment of stroke, internal bleeding, and fractures, while oncology specialists depend on them for tumor detection, staging, and radiation therapy planning. AI-powered image reconstruction, spectral imaging, and dose-reduction technologies are transforming the CT market, enhancing diagnostic accuracy while minimizing radiation exposure. The integration of real-time 3D imaging, deep learning-based anomaly detection, and low-dose CT protocols is making CT scanning safer and more efficient. Expanding applications in cardiac imaging, lung screening, and preventive health programs are increasing adoption across different healthcare systems. CT imaging also supports advancements in robotic surgery, precision medicine, and virtual autopsy procedures, further broadening its medical applications. Growing investments in portable and mobile CT units are improving accessibility, especially in rural and military healthcare settings. The widespread adoption of integrated radiology platforms, cloud-based image storage, and remote diagnostic solutions is helping healthcare providers improve workflow efficiency.

According to the research report "Global Computed Tomography (CT) Market Outlook, 2029," published by Bonafide Research, the Global Computed Tomography (CT) market is anticipated to grow at more than 6.49% CAGR from 2024 to 2029.The market growth is fueled by increasing adoption in hospitals, specialty clinics, and diagnostic imaging centers, where CT imaging is essential for oncology, neurology, cardiology, trauma care, and preventive screenings. The industry players such as GE Healthcare, Siemens Healthineers, Philips, and Canon Medical Systems dominate the market by offering high-speed multi-slice scanners, portable CT units, dual-source CT, and iterative reconstruction technologies that enhance image clarity while reducing radiation exposure. Companies differentiate by integrating AI-based noise reduction, real-time 3D visualization, and spectral imaging capabilities, making CT scans more precise and efficient. Siemens’ SOMATOM X.ceed and GE Healthcare’s Revolution Apex are gaining traction in North America and Europe due to enhanced cardiac imaging and low-dose protocols, while portable CT scanners are increasingly used in remote and emergency care settings. Sales strategies involve direct hospital partnerships, leasing models for cost-effective adoption, and cloud-based radiology solutions for remote diagnostics. Governments and private firms conduct lung cancer screening programs, AI-driven tuberculosis detection projects, and stroke imaging initiatives to expand access to CT diagnostics. Regulatory bodies like FDA, CE, and ISO enforce strict compliance on radiation dose limits, AI-based imaging interpretation, and device quality assurance to ensure patient safety and clinical accuracy. Innovations in photon-counting CT, spectral imaging, and deep learning-assisted diagnostics continue to redefine the CT market, making it an essential pillar of modern medical imaging.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample
Market Dynamics

Market Drivers

Rising Demand for Early Disease Diagnosis and Screening The increasing prevalence of chronic diseases like cancer, cardiovascular disorders, and neurological conditions is driving the demand for advanced imaging solutions. CT scans provide high-resolution cross-sectional images, enabling early detection and better treatment planning, making them indispensable in modern diagnostics.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst

Technological Advancements in CT ImagingInnovations such as spectral CT, photon-counting detectors, and AI-integrated imaging are enhancing diagnostic accuracy while reducing radiation exposure. AI-powered image reconstruction and automation are improving workflow efficiency in radiology departments, leading to faster and more precise diagnoses.

Market Challenges

High Cost of Equipment and MaintenanceAdvanced CT scanners with AI capabilities and multi-slice imaging are expensive, making them unaffordable for small healthcare centers, especially in low-income regions. The ongoing costs of maintenance, software updates, and radiation shielding further add to the financial burden.

Don't pay for what you don't need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari
Radiation Exposure Risks and Regulatory ComplianceAlthough CT imaging is essential for diagnostics, repeated exposure to ionizing radiation increases health risks. Stringent regulatory guidelines from agencies like the FDA and the European Medicines Agency require manufacturers to develop low-dose CT technology, which increases development costs and implementation challenges.

Market Trends

AI-Powered Automation in CT ImagingArtificial intelligence is revolutionizing CT scan interpretation by automating image analysis, reducing scan time, and enhancing diagnostic precision. AI algorithms assist radiologists in detecting anomalies faster, improving patient outcomes, and optimizing hospital workflows.

Growing Adoption of Portable and Point-of-Care CT ScannersThe demand for mobile and compact CT scanners is increasing, particularly in emergency care, ICUs, and remote healthcare settings. These portable solutions enable on-site imaging for critically ill patients, reducing the need for transportation and improving access to rapid diagnostics.

Segmentation Analysis

High slice CT is playing a crucial role in the global computed tomography (CT) market because it offers superior image resolution, faster scan times, and enhanced diagnostic accuracy, making it essential for complex medical conditions and advanced imaging needs.

Hospitals and diagnostic centers worldwide rely on high slice CT scanners, particularly 128-slice and 256-slice systems, to capture highly detailed images with reduced motion artifacts. These scanners are widely used in cardiology, oncology, neurology, and trauma care due to their ability to provide rapid, high-resolution imaging of the heart, brain, and other critical organs. In cardiac imaging, high slice CT enables precise coronary artery visualization, reducing the need for invasive angiography. The ability to conduct whole-body scans in just seconds enhances emergency and trauma care, allowing physicians to quickly assess internal injuries, brain hemorrhages, or stroke-related blockages. High slice CT technology minimizes radiation exposure while maintaining superior image clarity, making it a preferred choice in pediatric and oncology imaging. The growing prevalence of chronic diseases such as cardiovascular disorders and cancer drives the demand for these advanced CT systems. Manufacturers like Siemens Healthineers, GE Healthcare, and Philips continuously innovate in this segment, integrating AI-driven image reconstruction and automated workflow enhancements to improve diagnostic efficiency. The high slice CT systems support dual-energy imaging, allowing radiologists to differentiate between soft tissues, blood vessels, and bone structures with greater precision. Developed markets in North America and Europe lead in adoption due to their advanced healthcare infrastructure, while emerging economies in Asia-Pacific increasingly invest in high slice CT to enhance diagnostic capabilities. Government initiatives promoting early disease detection and the expansion of tele-radiology services further boost demand, ensuring high slice CT remains a critical component of modern medical imaging.

Oncology is a significant application in the global computed tomography (CT) market because it plays a crucial role in cancer detection, staging, treatment planning, and monitoring, offering high-resolution imaging that enables early diagnosis and precise tumor assessment.

Hospitals and diagnostic centers worldwide use CT scans extensively in oncology to visualize tumors, assess their size, shape, and location, and determine their relationship with surrounding tissues. High-speed multi-slice CT scanners provide detailed cross-sectional images, helping oncologists identify cancerous growths in the lungs, liver, brain, and other organs with remarkable accuracy. Physicians rely on contrast-enhanced CT imaging to differentiate between benign and malignant lesions, aiding in early intervention. CT technology also assists in radiation therapy planning by mapping tumor positions and optimizing treatment fields to minimize damage to healthy tissues. Advanced CT techniques, such as dual-energy and perfusion imaging, allow for better tumor characterization by analyzing blood flow and tissue composition. As cancer prevalence rises globally, the demand for CT-based oncology diagnostics continues to grow, particularly in regions with aging populations and increasing exposure to environmental risk factors. Leading healthcare companies like Siemens Healthineers, GE Healthcare, and Canon Medical Systems are integrating artificial intelligence into CT imaging to enhance diagnostic precision and automate tumor detection. In developed markets such as North America and Europe, government-led cancer screening programs and early detection initiatives drive CT adoption, while in emerging markets, expanding healthcare infrastructure and improved accessibility to diagnostic tools fuel demand. Additionally, tele-radiology advancements enable remote cancer diagnosis, ensuring that patients in underserved areas benefit from high-quality imaging.

Hospitals are a significant end user in the global computed tomography (CT) market because they serve as primary healthcare facilities where CT scans are widely used for diagnosing diseases, guiding treatments, and monitoring patient conditions across various medical specialties.

Hospitals rely on CT imaging for a broad range of applications, from emergency care to routine diagnostics, making it an essential tool in patient management. Emergency departments use CT scans for rapid assessment of trauma, stroke, and internal bleeding, where immediate imaging can be lifesaving. In oncology, hospitals perform high-resolution CT scans to detect tumors, stage cancers, and plan treatments like surgery or radiation therapy. Cardiology departments depend on coronary CT angiography to evaluate heart diseases, detect arterial blockages, and assess risks of conditions like aneurysms. Neurology specialists use CT to diagnose strokes, brain injuries, and neurological disorders, as the technology provides fast and detailed brain imaging. Multislice CT scanners, such as 64-slice or high-slice systems, enable precise imaging with reduced radiation exposure, improving patient safety. Large hospitals often invest in advanced CT systems with artificial intelligence integration, which enhances diagnostic accuracy and reduces scan times. Healthcare institutions in developed regions, such as North America and Europe, frequently upgrade CT equipment to comply with regulatory requirements and enhance operational efficiency. Emerging economies are also expanding hospital-based CT services due to increasing healthcare investments and government initiatives. Additionally, hospitals partner with medical imaging companies for maintenance services, software upgrades, and training programs to optimize CT utilization.

Regional Analysis

North America dominates the global computed tomography (CT) market because of its advanced healthcare infrastructure, high adoption of cutting-edge medical imaging technologies, strong regulatory framework, and increasing demand for early disease diagnosis.

Hospitals, diagnostic imaging centers, and specialized clinics across the United States and Canada consistently invest in high-performance CT systems to improve patient outcomes. The region's healthcare providers prioritize early detection of chronic diseases, such as cancer, cardiovascular conditions, and neurological disorders, which require precise imaging solutions. Government agencies, including the U.S. Food and Drug Administration (FDA), establish strict guidelines for CT scanner safety, radiation dose management, and quality assurance, encouraging manufacturers to develop innovative and compliant imaging solutions. Leading companies, such as GE Healthcare, Siemens Healthineers, and Philips, maintain strong R&D investments in North America, driving the development of AI-enhanced CT systems with faster scan times, reduced radiation exposure, and improved diagnostic accuracy. The presence of numerous research institutions and teaching hospitals supports the rapid adoption of novel CT imaging techniques, including spectral and photon-counting CT. Reimbursement policies by Medicare and private insurers ensure accessibility to CT scans, increasing patient volume in hospitals and outpatient imaging centers. The rising incidence of age-related diseases and trauma cases further fuels the demand for high-slice CT scanners in emergency departments. Additionally, telehealth expansion has encouraged remote diagnostics, where cloud-based CT image sharing improves collaboration among radiologists and specialists. North America's market strength is further reinforced by ongoing clinical trials, strategic partnerships between medical device companies and healthcare providers, and government funding for advanced imaging research.

Key Developments

• In February 2024, Koning Health received regulatory approval from the Federal Authority for Nuclear Regulation (FANR) in the United Arab Emirates (UAE), signifying a pivotal achievement in the company's growth and commitment to global health innovation. This regulatory approval positions Koning as the foremost provider of breast CT technology in the UAE, therefore establishing a new benchmark in breast imaging and treatment in the area.
• In January 2024, GE HealthCare announced the acquisition of MIM Software, a prominent provider of AI-driven solutions for medical image processing. MIM Software provides advanced solutions in radiation oncology, molecular radiotherapy, diagnostic imaging, and urology across diverse healthcare environments. GE HealthCare intends to leverage MIM Software's sophisticated image analytics and digital workflow functionalities to foster innovation and improve patient care in many healthcare sectors worldwide.
• In January 2023, GE HealthCare signed into an agreement to buy IMACTIS, a France-based innovation in the rapidly growing field of Computed Tomography (CT) interventional guidance across various healthcare settings.
• In November 2023, Canon Medical Systems Corp. announced substantial enhancements to its CT line, launching two new scanners at the Radiological Society of North America Congress (RSNA). The new flagship system, Aquilion ONE / INSIGHT Edition, and the high-throughput system, Aquilion Serve SP, are included among them.

Considered in this report
* Historic year: 2018
* Base year: 2023
* Estimated year: 2024
* Forecast year: 2029

Aspects covered in this report
* Computed Tomography (CT) Market with its value and forecast along with its segments
* Country-wise Computed Tomography (CT) Market analysis
* Various drivers and challenges
* On-going trends and developments
* Top profiled companies
* Strategic recommendation

By Type:
• Low Slice
• Medium Slice
• High Slice

By Application:
• Oncology
• Cardiovascular
• Neurology
• Musculoskeletal
• Others

By End-use:
• Hospitals
• Diagnostic Centers
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analysing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to Computed Tomography (CT) industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

Request Table of Contents

First Name

Last Name

Company Name

Job Title

Business Email

Contact Number

Description

Market Research FAQs

According to the research report "Global Computed Tomography (CT) Market Outlook, 2029," published by Bonafide Research, the Global Computed Tomography (CT) market is anticipated to grow at more than 6.49% CAGR from 2024 to 2029.The market growth is fueled by increasing adoption in hospitals, specialty clinics, and diagnostic imaging centers, where CT imaging is essential for oncology, neurology, cardiology, trauma care, and preventive screenings.

The report uses 2018 as the historic year, 2023 as the base year, 2024 as the estimated year, with forecasts up to 2029.

The Global Computed Tomography (Ct) Market is analysed by type: (Low Slice, Medium Slice, High Slice); application: (Oncology, Cardiovascular, Neurology, Musculoskeletal, Others); end-use: (Hospitals, Diagnostic Centers).

The report covers Global.

This report is open for pre-booking. Pre-book it to receive the full report as soon as it is released. You can also request a free sample and the table of contents in the meantime.

Yes. Bonafide Research can add countries, segments or company profiles to match your requirements. Request customisation.
Logo

Global Computed Tomography (Ct) Market Outlook, 2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Claude Summarize

Contact usWe are friendly and approachable, give us a call.